FactSet Research Systems Inc.

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Why Did FactSet Research Systems (FDS) Move Today?

AI-generated analysis

📈 FactSet Research Systems affirmed a quarterly cash dividend of $1.16 per share, payable on September 17, 2026.

🤝 The company is advancing its AI partnership with Google Cloud while continuing its ongoing share repurchase program.

📉 Short-term momentum is strong with a 10.59% return in the last 30 days and 27.60% in the last 90 days.

📉 Longer-term performance lags significantly, showing a 22.41% decline in total shareholder return over the past year.

💰 Analysts forecast earnings to reach $721.8 million by August 2029, up from $566.0 million today.

⚖️ The stock currently trades at a closing price of $285.41 versus an analyst fair value estimate of $255.06.

📉 Higher technology costs and a softer banking backdrop pose risks to margins and subscription growth assumptions.

📊 FactSet Research Systems trades at a P/E ratio of 17.9x, which is higher than the estimated fair ratio of 16.1x.

🏢 The company's valuation remains below peers at 22.3x and the wider US Capital Markets industry average of 38.2x.

Bullish Signals
  • FactSet Research Systems recently affirmed a regular quarterly cash dividend of $1.16 per share, providing consistent cash returns to shareholders.
  • The company is actively executing an ongoing share repurchase program alongside its strategic AI partnership with Google Cloud.
  • Short-term momentum is robust, evidenced by a 10.59% share price return over the last 30 days and a 27.60% return over the past 90 days.
  • Analysts project earnings to grow significantly to $721.8 million (EPS of $22.29) by August 2029, up from $566.0 million today.
Risk Factors
  • The stock's recent rebound contrasts with a 1-year total shareholder return that declined 22.41%, indicating pressure on longer-term holders.
  • Analyst fair value estimates of $255.06 sit lower than the current share price of $285.41, suggesting the stock may be running ahead of fundamentals.
  • The company faces potential margin weakness and slower subscription growth due to higher technology costs and a softer banking and asset management backdrop.
  • The stock trades at a P/E ratio of 17.9x, which is higher than the estimated fair ratio of 16.1x, presenting a potential valuation risk if sentiment shifts.
Full Analysis
FactSet Research Systems (FDS) recently affirmed a regular quarterly cash dividend of $1.16 per share, payable on September 17, 2026 to shareholders of record as of August 31, 2026. This decision coincides with the company's ongoing share repurchase program and its strategic AI partnership with Google Cloud, providing investors with fresh information on cash returns amidst a period of heightened focus on the firm's technological integration. The stock has experienced significant short-term momentum, posting a 10.59% return over the last 30 days and a 27.60% return over the past 90 days, driven largely by the AI partnership and dividend affirmation. However, this recent rebound contrasts sharply with a 1-year total shareholder return that declined by 22.41%, suggesting that longer-term holders remain under pressure while short-term sentiment has surged. Analysts project FactSet Research Systems' earnings to reach $721.8 million (EPS of $22.29) by August 2029, up from $566.0 million today, though current analyst fair value estimates sit at $255.06 compared to a closing price of $285.41. This valuation gap suggests the stock may be trading ahead of fundamentals, with analysts noting that higher technology costs and a softer banking backdrop could weaken margins and subscription growth assumptions. Valuation metrics indicate mixed signals for FactSet Research Systems; the stock trades at a P/E ratio of 17.9x, which is higher than the estimated fair ratio of 16.1x but remains below peers at 22.3x and the wider US Capital Markets industry average of 38.2x. While sentiment is currently mixed regarding the company's trajectory, the divergence between short-term price action and longer-term analyst targets highlights a potential valuation risk or an opportunity for patient investors depending on how growth expectations shift.